Shanghai Haohai Biological Technology Co (HKSE:06826) Cash Flow for Dividends : HK$0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Cash Flow for Dividends?

Shanghai Haohai Biological Technology Co's cash flow for dividends for the three months ended in Mar. 2024 was HK$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shanghai Haohai Biological Technology Co's annual payment of dividends increased from Dec. 2021 (HK$-108 Mil) to Dec. 2022 (HK$-136 Mil) but then declined from Dec. 2022 (HK$-136 Mil) to Dec. 2023 (HK$-75 Mil).

Shanghai Haohai Biological Technology Co Cash Flow for Dividends Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Cash Flow for Dividends Chart

Shanghai Haohai Biological Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-89.05

-147.05

-107.64

-136.12

-74.94

Shanghai Haohai Biological Technology Co Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Haohai Biological Technology Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0 Mil.

Shanghai Haohai Biological Technology Co Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haohai Biological Technology Co (HKSE:06826) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

688366:China

Address

No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN

Website

https://www.3healthcare.com

Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Executives

Morgan Stanley	2201 Interest of corporation controlled by you
Dalton Investments Llc	2102 Investment manager
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Templeton Investment Counsel, Llc	2102 Investment manager
Kabouter Management Llc	2102 Investment manager
Royal Bank Of Canada	2201 Interest of corporation controlled by you
Kabouter International Insight Fund, Llc	2102 Investment manager
Prudence Investment Management (hong Kong) Limited	2102 Investment manager

Shanghai Haohai Biological Technology Co (HKSE:06826) Headlines

No Headlines